BioELife Corp.
LITH
$0.0001
$0.000.00%
OTC PK
| 09/30/2019 | 06/30/2019 | 03/31/2019 | 12/31/2018 | 09/30/2018 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | 0.00% | 0.00% | 0.00% | -55.56% |
| Gross Profit | -- | 0.00% | 0.00% | 0.00% | 55.56% |
| SG&A Expenses | -- | -25.52% | -28.35% | -41.27% | 16.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -25.09% | -28.07% | -41.01% | 15.39% |
| Operating Income | -- | 25.09% | 28.07% | 41.01% | -15.39% |
| Income Before Tax | -- | -36,071.43% | 12.09% | -36.51% | 139.64% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -36,071.43% | 12.09% | -36.51% | 139.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -36,071.43% | 12.09% | -36.51% | 139.64% |
| EBIT | -- | 25.09% | 28.07% | 41.01% | -15.39% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -- | -8,204.35% | 15.85% | -27.41% | 133.90% |
| Normalized Basic EPS | -- | 51.79% | 27.79% | 25.60% | 7.19% |
| EPS Diluted | -- | -8,204.35% | 15.85% | -27.41% | 133.90% |
| Normalized Diluted EPS | -- | 51.79% | 27.79% | 25.60% | 7.19% |
| Average Basic Shares Outstanding | -- | 3.05% | 4.22% | 7.18% | 8.47% |
| Average Diluted Shares Outstanding | -- | 3.05% | 4.22% | 7.18% | 8.47% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |